Once-daily telmisartan compared with enalapril in the treatment of hypertension

Advances in Therapy

Volumn 15, Issue 4, 1998, Pages 229-240

  Smith, David H G ^a  

^a Orange County Heart Institute and Research Center   (United States)

Author keywords

Dose ranging study; Enalapril; Hypertension; Telmisartan

Indexed keywords

ENALAPRIL; TELMISARTAN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MALE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VERTIGO;

EID: 0031694644     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Nicholls MG, Charles CJ, Crozier IG, et al. Blockade of the renin-angiotensin system. J Hypertens. 1994;10(suppl):S95-S103.
2. Gavras I, Gavras H. Angiotensin II - possible adverse effects on arteries, heart, brain, and kidney: experimental, clinical, and epidemiological evidence. In: Robertson JIS, Nicholls MG, eds. The Renin-Angiotensin System, I. Biochemistry/Physiology. London: Gower Medical Publishing; 1993:40.1-40.11.
3. Brunner HR, Waeber B, Nussberg J. Angiotensin converting enzyme inhibitors. In: Cardiovascular Drug Therapy. 2nd ed. Philadelphia: WB Saunders; 1996:690-711.